Cargando…

Micafungin as antifungal prophylaxis in non-transplanted haemotological patients

INTRODUCTION: Fungal infections are a major cause of morbidity and mortality in the haematological patients. These infections are mainly due to Candida spp. and Aspergillus spp. Mortality by these infections is high, but rates have descended in the latest series due to better antifungal agents. Echi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Villaescusa, Teresa, Vázquez, Lourdes, Bergua, Juan Miguel, García, Julio, Romero, Antonio, Olave, M. Teresa, Belmonte, Daniel García, de Llano, M. Paz Queipo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedad Española de Quimioterapia 2020
Materias:	Original
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6987625/ https://www.ncbi.nlm.nih.gov/pubmed/31865649 http://dx.doi.org/10.37201/req/067.2019

Ejemplares similares

Use of micafungin as antifungal prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT) in Spain (GETH-MIC)
por: López-Sánchez, Cristina, et al.
Publicado: (2020)

New anti–coagulant therapies set to revitalise clinical haemotology practice
por: J, AALBERS, et al.
Publicado: (2010)

412. Clinical and Pharmacoeconomic Evaluation of Antifungal Prophylaxis With Continuous Micafungin Compared to Posaconazole With Micafungin Bridging in Patients Undergoing Allogeneic Stem Cell Transplantation: A 6-Year Cohort Analysis
por: Heimann, Sebastian M, et al.
Publicado: (2018)

Evaluation of the synergistic antifungal activity of micafungin and voriconazole plus sertraline against Candida auris
por: Alanís-Ríos, Sergio A., et al.
Publicado: (2022)

Antifungal Prophylaxis in Immunocompromised Patients
por: Vazquez, Lourdes
Publicado: (2016)

Identification of Potentially Unnecessary Micafungin Use Patterns: Opportunities for Antifungal Stewardship Interventions
por: Concha, Miguel Chavez, et al.
Publicado: (2021)

Micafungin prophylaxis for acute leukemia patients undergoing induction chemotherapy
por: Park, Hyunkyung, et al.
Publicado: (2019)

Evaluation of an Antifungal Stewardship Initiative Targeting Micafungin at an Academic Medical Center
por: Keck, J. Myles, et al.
Publicado: (2023)

Treatment and prophylaxis of invasive candidiasis with anidulafungin, caspofungin and micafungin - review of the literature
por: Glöckner, A
Publicado: (2011)

Cost Analysis of the Use of Voriconazole, Posaconazole and Micafungin in the Primary Prophylaxis of Invasive Fungal Infections in Recipients of Allogeneic Hematopoietic Stem Cell Transplants
por: Grau, Santiago, et al.
Publicado: (2015)

Micafungin induced apoptosis in Candida parapsilosis independent of its susceptibility to micafungin
por: Shirazi, Fazal, et al.
Publicado: (2015)

594. Micafungin Prophylaxis in Acute Myeloid Leukemia Adult Patients Undergoing Induction Chemotherapy
por: Ross, Justine Abella, et al.
Publicado: (2021)

Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis()
por: Denning, David W., et al.
Publicado: (2006)

Are we near to the end of the standard dose of micafungin?
por: Agrifoglio, Alexander, et al.
Publicado: (2018)

Clinical Pharmacokinetics and Pharmacodynamics of Micafungin
por: Wasmann, Roeland E., et al.
Publicado: (2017)

A Genome-Wide Screening of Potential Target Genes to Enhance the Antifungal Activity of Micafungin in Schizosaccharomyces pombe
por: Zhou, Xin, et al.
Publicado: (2013)

Effect of antifungal stewardship on micafungin prescribing practices in intensive care units at a tertiary-care hospital
por: Arya, Radhika, et al.
Publicado: (2023)

Pooled analysis of safety for micafungin
por: Cornely, OA, et al.
Publicado: (2008)

Review of the pharmacology and clinical studies of micafungin
por: Bormann, Alison M, et al.
Publicado: (2009)

Treatment and prophylaxis of invasive candidiasis with anidulafungin, caspofungin and micafungin and its impact on use and costs - review of the literature
por: Wilke, MH
Publicado: (2011)

Antifungal Prophylaxis
por: Johnson, Douglas Clark, et al.
Publicado: (2021)

Glutathione Metabolism in Candida albicans Resistant Strains to Fluconazole and Micafungin
por: Maras, Bruno, et al.
Publicado: (2014)

Reply: Antifungal Prophylaxis
por: Pennington, Kelly M., et al.
Publicado: (2021)

The limited role of serum galactomannan assay in screening for invasive pulmonary aspergillosis in allogeneic stem cell transplantation recipients on micafungin prophylaxis: a retrospective study
por: Kim, Ryul, et al.
Publicado: (2017)

Cardiac Safety of High-dose Micafungin
por: Stover, Kayla R., et al.
Publicado: (2017)

Pharmacokinetics of Micafungin in Critically Ill Patients
por: Gastine, Silke, et al.
Publicado: (2019)

Micafungin in the treatment of candiduria: A case series
por: Kane, Lauren E., et al.
Publicado: (2016)

Micafungin in the treatment of invasive candidiasis and invasive aspergillosis
por: Wiederhold, Nathan P, et al.
Publicado: (2009)

Randomized Trial of Micafungin for the Prevention of Invasive Fungal Infection in High-Risk Liver Transplant Recipients
por: Saliba, Faouzi, et al.
Publicado: (2015)

2737. Real World Evaluation of Antifungal Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplant (aHSCT) Patients, Is Routine Antifungal Prophylaxis Needed?
por: Perreault, Sarah, et al.
Publicado: (2023)

Antifungal prophylaxis in critically ill patients
por: Silvestri, Luciano, et al.
Publicado: (2008)

Pharmacokinetics of micafungin in patients with severe burn injuries
por: Sasaki, J, et al.
Publicado: (2012)

Pharmacokinetics of micafungin in patients with severe burn injuries
por: Sasaki, J, et al.
Publicado: (2011)

Micafungin for the treatment of pediatric invasive fungal infections
por: Arrieta, A, et al.
Publicado: (2009)

Pharmacokinetics of micafungin in subjects with severe hepatic dysfunction
por: Undre, Nasrullah, et al.
Publicado: (2014)

Antiviral activity of micafungin against enterovirus 71
por: Kim, Chonsaeng, et al.
Publicado: (2016)

Los intelectuales y la dictadura de Primo de Rivera /
por: García Queipo de Llano, Genoveva, 1945-
Publicado: (1988)

SUBA-Itraconazole for Primary Antifungal Prophylaxis After Allogeneic Hematopoietic Cell Transplantation
por: Lindsay, Julian, et al.
Publicado: (2021)

Recommendations on the use of azole antifungals in hematology-oncology patients
por: Azanza, José Ramón, et al.
Publicado: (2023)

Fatal breakthrough mucormycosis in a multivisceral transplant patient receiving micafungin: Case report and literature review
por: Louis-Auguste, John R., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_tn4qpe6n4d4e9mdneu27t6s06n